AI assistant
BioCardia, Inc. — Director's Dealing 2020
Mar 27, 2020
35081_dirs_2020-03-27_f8caac84-9c60-4fbe-be36-367289b58208.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2019-08-27
Reporting Person: Altman Peter (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-27 | Common Stock | A | 12126 | — | Acquired | 184037 | Direct |
| 2020-03-11 | Common Stock | F | 4958 | $3.60 | Disposed | 179079 | Direct |
Footnotes
F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on January 29, 2020.
F2: This share amount reflects the number of shares beneficially owned as of the filing date of this Form 4.
F3: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person.